These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6431473)

  • 1. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
    Weiner I; Lubow RE; Feldon J
    Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
    Feldon J; Weiner I
    Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early handling and latent inhibition in the conditioned suppression paradigm.
    Weiner I; Feldon J; Ziv-Harris D
    Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of latent inhibition to a contextual stimulus with systemic amphetamine.
    Norman C; Cassaday HJ
    Neurobiol Learn Mem; 2004 Jul; 82(1):61-4. PubMed ID: 15183172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
    Weiner I; Bernasconi E; Broersen LM; Feldon J
    Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroleptic-like effect of ceronapril on latent inhibition.
    Weiner I; Smith AD; Rawlins JN; Feldon J
    Neuroscience; 1992 Jul; 49(2):307-15. PubMed ID: 1359453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.
    Killcross AS; Dickinson A; Robbins TW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):185-95. PubMed ID: 7862894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
    Feldon J; Weiner I
    Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
    Weiner I; Schiller D; Gaisler-Salomon I
    Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basolateral amygdala lesions do not disrupt latent inhibition.
    Weiner I; Tarrasch R; Feldon J
    Behav Brain Res; 1995 Dec; 72(1-2):73-81. PubMed ID: 8788859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the new antipsychotic, sertindole, on latent inhibition in rats.
    Weiner I; Kidron R; Tarrasch R; Arnt J; Feldon J
    Behav Pharmacol; 1994 Apr; 5(2):119-124. PubMed ID: 11224259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
    Zuckerman L; Rimmerman N; Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):298-307. PubMed ID: 12827344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated.
    Weiner I; Tarrasch R; Bernasconi E; Broersen LM; Rüttimann TC; Feldon J
    Pharmacol Biochem Behav; 1997 Apr; 56(4):817-26. PubMed ID: 9130310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.